Quick Answer
Camp4 Therapeutics Corp reported Net Income of -$80.40 million for fiscal year 2025.
Camp4 Therapeutics Corp Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$80.40M | -55.2% |
| 2024 | -$51.79M | -5.1% |
| 2023 | -$49.29M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$15.10M | -12.0% | -20.0% |
| June 30, 2025 | -$12.59M | -0.1% | -1.2% |
| March 31, 2025 | -$12.43M | +0.2% | +7.8% |
| September 30, 2024 | -$13.48M | -15.3% | -7.3% |
| June 30, 2024 | -$12.57M | -3.9% | -0.9% |
| March 31, 2024 | -$12.46M | +0.4% | -6.5% |
| September 30, 2023 | -$11.70M | — | +3.3% |
| June 30, 2023 | -$12.10M | — | +3.2% |
- Camp4 Therapeutics Corp showed a decrease of -55.2% in Net Income compared to the prior fiscal year.
- Over the 2023–2025 period, Camp4 Therapeutics Corp’s net income has declined by 63.1% (from -$49.29 million to -$80.40 million).
- The most recent figure is from Camp4 Therapeutics Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: